Newcastle University Centre for Cancer

Their important research aims to uncover possible causes behind the rise in early onset colorectal cancer (EOCRC) and improve early diagnosis and support services for those affected. 🧬💙

We're proud to see this vital work being recognised and funded! 🙌

🎉 Huge congratulations to Prof. Linda Sharp, Dr. Laura Woods & Dr. Christina Dobson on receiving a £40,000 grant from @HDR_UK North for their 9-month project: “Epidemiology of Early Onset Colorectal Cancer in England” 👏

#ColorectalCancer #EarlyDiagnosis #PublicHealth

🚨 New publication

Prof. Mike Waring & team have advanced micelle-promoted DNA-encoded library synthesis through surfactant optimisation.

Published in @orgbiomolchem.rsc.org.

🔬 Read more: pubs.rsc.org/.../ArticleL...

#CancerResearch #MedicinalChemistry #DrugDiscovery

Images of two individuals looking at the camera. Both are headshots with each person smiling. A woman wears a navy jumper and a silver cross necklace; a man wears a smart, blue and red striped shirt.

Congratulations to two of our scientists, professors Ruth Plummer and Stephen O’Brien, who have been appointed as national cancer drug experts by @england.nhs.uk, leading in ensuring patients have the best possible access to new cancer treatments.

#WeAreNCL

Her clever Newcastle-themed example charmed the audience, helping to show why #LongReads > #ShortReads for this type of research.

Well done Eleanor! 🔬

🏆 NU Cancer Conference 2025: Prize Winner Spotlight

PhD student Eleanor Woodward won a Flash Talk Award for her work on characterising structural variants in tumour samples using long-read sequencing via
@oxfordnanopore.bsky.social platforms. 🧬

#CancerResearch #PhDLife #WomenInSTEM

The funding will help support his research efforts to understand how radiation can affect tumours, the immune system and liver tissue, and how radiation could make immunotherapies more effective.

Well done Abdullah!

Congratulations to Abdullah Malik, who has recently been awarded a support grant from LIVErNorth, a support charity for #liver #cancer patients based in the North East.

Louisa identified new therapeutics that indirectly target MYC—as single agents or as drug combinations 💊

These show great pre‑clinical promise, with hopes of bringing them to the clinic in the future.

Great job Louisa! 👏

🏆 #NUCancer Conference 2025: Prize Winner Spotlight

Congratulations to Louisa Taylor, PhD, winner of a Flash Talk Award for her cutting-edge work on high-risk MYC-amplified #medulloblastoma. 🔬💡

#childhoodcancer #childhoodcancerawareness #pediatriccancer #cancerresearch

Generation of evidence-based carboplatin dosing guidelines for neonates and infants - British Journal of Cancer British Journal of Cancer - Generation of evidence-based carboplatin dosing guidelines for neonates and infants

This prize was awarded in recognition of her 2023 manuscript titled:

“Generation of evidence-based carboplatin dosing guidelines for neonates and infants”

You can read the manuscript yourself here:
www.nature.com/articles/s41...

🎉Congratulations to Dr. Shelby Barnett on receiving the joint EPHAR-EACPT Young Investigator Award in translational Pharmacology.

Great work Shelby! 👏

#NUcancer

We would like to extend a heartfelt thank you to everyone who contributed to this achievement, and to our members, collaborators, funders and supporters who have helped make this possible.

We're delighted to share that @newcastleuni.bsky.social has officially approved renewal of the #NUCancerCentre for 2025-30.

We look forward to continuing this important journey together over the next five years.

The NU Conference was a big success with a superb plenary from Ram DasGupta (CRUK Scotland). Prizes for talks - J Dishington (1st) and H Stewart; flash talks - E Woodward (1st), L Taylor (2nd); posters - E Hackney (1st), K Papa (2nd). Congrats and to all presenters for giving us a memorable day!

Dr Amy Collins is busy at her poster on modelling hepatocellular carcinoma at the 2025 EASL Liver Cancer Summit in Paris. Funding for her work from Cancer Research U.K.

Human-correlated genetic models identify precision therapy for liver cancer - Nature As proof of principle, an analysis using a suite of human-aligned immunocompetent mouse models of hepatocellular carcinoma identifies a promising therapeutic candidate, cladribine, which acts in ...

An important new study on the genetics of liver cancer published today in Nature led by Prof Tom Bird of Edinburgh University with contributions from @damann1.bsky.social, @jleslie1.bsky.social and others of @nucancer.bsky.social.

It was a pleasure hosting @walkolab.bsky.social from the Bart's Centre for Squamous Cancer in our NUCoRE Cancer seminar series this week where he told us about his exciting research on transcriptional addiction.

Our talented PhD student Keara wins a regional prize for her work on developing a 96-well scale model of liver cancer tumour microenvironment. Congratulations Keara!

Today is World Cancer Day. At the NU Centre for Cancer we are dedicated to working towards more effective and gentler treatments for cancer patients.

NUCancer Newsletter - Feb 2025 The NUCancer Executive Board is looking for volunteers to help look after and create new posts for our social accounts (Bluesky, LinkedIn, X and Facebook), if you are keen to get involved, we'd love t

4 NU Cancer PhD studentships have just been awarded! Projects include multi-omic analysis of childhood medulloblastoma, modelling prostate cancer, identifying mitochondrial targets, and functional investigation of TP53 mutations in Burkitt Lymphoma. sway.cloud.microsoft/lBcDTPEyC7TD...

A great opportunity for PhD study on an important cancer with supervision by one of our rising stars!

PhD studentship in paediatric brain tumour research – Integrative multi-omic analyses of childhood medulloblastoma for improved personalised therapies at Newcastle University on FindAPhD.com PhD Project - PhD studentship in paediatric brain tumour research – Integrative multi-omic analyses of childhood medulloblastoma for improved personalised therapies at Newcastle University, list...

PhD post available: Are you interested in using contemporary ‘omics approaches to uncover clinically-relevant biology in medulloblastoma, the most common malignant brain tumour in children? Join our Childhood Brain Tumour Research team @nucancer.bsky.social
See www.findaphd.com/phds/project...

Blood Cancer UK | Blood cancer researcher recognised in King’s New Years Honours The King’s New Years Honours list has been announced with Blood Cancer UK's trustee awarded an OBE for services to children.

We are very proud that our very own Professor Christine Harrison has been deservedly recognised with an OBE for her work on improving the scientific knowledge and care of childhood leukaemia. bloodcancer.org.uk/news/blood-c...

What role can NHS scientists play in delivering the genomic revolution? - Cancer Research UK - Cancer News David Wells on building an NHS workforce ready for genomic medicine, which is rapidly changing how we understand, diagnose and treat cancer.

The genomic revolution has the potential to transform cancer care 🔬

NHS specialists play a crucial role in cancer care, and expanding the NHS workforce and integrating scientists into care teams is key to unlocking the potential of genomics 👇 cruk.ink/4goGNmD

The 65th British Association for Cancer Research Meeting in Edinburgh June 2025.

Congratulations to Kenneth Tan who passed his PhD viva on Tuesday 🎉 Kenneth has also recently taken up a position as a Technical Specialist in our structural biology group. Many thanks to his examiners, @nucancer.bsky.social's Luke Gaughan and @universityofleeds.bsky.social's Richard Bayliss!

We are one of just 7 UK cancer centres that are contributing to the CRUK Black Leaders in Cancer PhD Scholarship Programme. We have 10 exciting projects on offer to eligible candidates of Black heritage backgrounds. Read more about the scheme and what we have on offer www.ncl.ac.uk/cancer/train...

Thank you!

Did you know that scientists in our @cruk-si.bsky.social Drug Discovery Unit were the brains behind Rucaparib (PARP inhibitor) and Erdafitinib (FGFR inhibitor, both now clinically approved cancer medicines. Read more about our ground breaking drug discovery science here www.ncl.ac.uk/cancer/our-r...